The Board of Dr. Reddy’s Laboratories Limited has approved the fund infusion by way of investment in equity shares of Dr. Reddy’s Laboratories LLC, Russia, a step-down wholly-owned subsidiary (DRL Russia), upto an amount of Rs. 600 crores.

Dr. Reddy’s Laboratories Limited has informed that the company has made an investment of Rs. 565.40 crore in DRL Russia for a total equity stake of 45.19%. Dr. Reddy’s Laboratories LLC, Russia, is a step-down wholly-owned subsidiary of Dr. Reddy’s Laboratories Limited.

The fund infused by the company into DRL Russia will be used for working capital requirements. The turnover of DRL Russia for FY2025 was Rs. 2,347 crore.

DRL Russia is a pharmaceutical company registered in the Russian Federation distributing pharmaceutical medicines in the country.